{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:23:24Z","timestamp":1770999804451,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mundipharma Pharmaceuticals LTd\u2019s"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["asthma res and pract"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Asthma affects the lives of hundred million people around the World. Despite notable progresses in disease management, asthma control remains largely insufficient worldwide, influencing patients\u2019 wellbeing and quality of life. Poor patient handling of inhaling devices has been identified as a major persistent problem that significantly reduces inhaled drugs\u2019 efficacy and is associated with poor adherence to treatment, impairing clinical results such as asthma control and increasing disease-related costs. We herein review key research and development (R&amp;D) innovation in inhaler devices, highlighting major real-world critical errors in the handling and inhalation technique with current devices and considering potential solutions. Furthermore, we discuss current evidence regarding breath-triggered inhalers (BTI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main body<\/jats:title><jats:p>The two most common significant problems with inhalers are coordinating actuation and inhalation with pressurized metered-dose inhalers (pMDIs), and the need to inhale forcibly with a dry powder inhaler. BTI R&amp;D plans were designed to overcome these problems. Its newest device k-haler\u00ae has several other important features, generating a less forceful aerosol plume than previous pMDIs, with efficient drug delivery and lung deposition, even in patients with low inspiratory flow. The local and systemic bioavailability of fluticasone propionate and formoterol (FP\/FORM) administered via k-haler\u00ae has been shown to be therapeutically equivalent when administered via the previous FP\/FORM pMDI. This device requires very few steps and has been considered easy to use (even at first attempt) and preferred by the patients in a randomized crossover study. In our country, FP\/FORM k-haler is available without additional costs compared to FP\/FORM pMDI. All devices continue to require education and regular checking of the correct inhalation technique.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>BTI R&amp;D can bring advantage over current available inhalers, avoiding the two most common identified critical errors in inhalation technique. K-haler\u00ae BTI is currently available, without an increased cost, and approved for adolescents and adults with asthma in whom treatment with inhaled combined therapy with long-acting beta<jats:sub>2<\/jats:sub>-agonists and corticosteroids is indicated. Its attractive and practical design to facilitate its use has been awarded. K-haler\u00ae represents added value through innovation to fulfill actual asthma patient needs, thus with potential relevant impact in asthma management and effective control.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40733-020-00057-7","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T10:02:39Z","timestamp":1591437759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Asthma management with breath-triggered inhalers: innovation through design"],"prefix":"10.1186","volume":"6","author":[{"given":"M\u00e1rio","family":"Morais-Almeida","sequence":"first","affiliation":[]},{"given":"Helena","family":"Pit\u00e9","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Carlos Robalo","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Eurico","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Todo-Bom","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Vicente","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Agostinho","family":"Marques","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"key":"57_CR1","unstructured":"Global Initiative for Asthma (GINA). GINA Report, Global Strategy for Asthma Management and Prevention. [http:\/\/ginasthma.org\/2019-gina-report-global-strategy-for-asthma-management-and-prevention\/] Accessed on March 2020."},{"issue":"5","key":"57_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaip.2016.03.002","volume":"4","author":"F Braido","year":"2016","unstructured":"Braido F, Chrystyn H, Baiardini I, Bosnic-Anticevich S, van der Molen T, Dandurand RJ, et al. \u201cTrying, but failing\u201d - the role of inhaler technique and mode of delivery in respiratory medication adherence. J Allergy Clin Immunol Pract. 2016;4(5):823\u201332.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"57_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.rmed.2006.01.008","volume":"100","author":"GK Crompton","year":"2006","unstructured":"Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the aerosol drug management improvement team. Respir Med. 2006;100(9):1479\u201394.","journal-title":"Respir Med"},{"key":"57_CR4","volume-title":"WHO adherence meeting report","author":"E Sabate","year":"2001","unstructured":"Sabate E. WHO adherence meeting report. Geneva: World Health Organization; 2001."},{"issue":"1","key":"57_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rmed.2012.09.017","volume":"107","author":"D Price","year":"2012","unstructured":"Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, et al. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med. 2012;107(1):37\u201346.","journal-title":"Respir Med"},{"issue":"9","key":"57_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.rmed.2010.04.012","volume":"104","author":"J Haughney","year":"2010","unstructured":"Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med. 2010;104(9):1237\u201345.","journal-title":"Respir Med"},{"issue":"6","key":"57_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","volume":"105","author":"AS Melani","year":"2011","unstructured":"Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930\u20138.","journal-title":"Respir Med"},{"issue":"5","key":"57_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/jamp.2009.0785","volume":"23","author":"GN Rootmensen","year":"2010","unstructured":"Rootmensen GN, van Keimpema AR, Jansen HM, de Haan RJ. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. J Aerosol Med Pulm Drug Deliv. 2010;23(5):323\u20138.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"57_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/089426803769017613","volume":"16","author":"M Molimard","year":"2003","unstructured":"Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16(3):249\u201354.","journal-title":"J Aerosol Med"},{"issue":"5","key":"57_CR10","first-page":"332","volume":"68","author":"A Lahdensuo","year":"1986","unstructured":"Lahdensuo A, Muittari A. Bronchodilator effects of a fenoterol metered dose inhaler and fenoterol powder in asthmatics with poor inhaler technique. Eur J Respir Dis. 1986;68(5):332\u20135.","journal-title":"Eur J Respir Dis"},{"issue":"2","key":"57_CR11","first-page":"93","volume":"70","author":"S Lindgren","year":"1987","unstructured":"Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis. 1987;70(2):93\u20138.","journal-title":"Eur J Respir Dis"},{"issue":"1","key":"57_CR12","first-page":"49","volume":"17","author":"S Newman","year":"1991","unstructured":"Newman S, Talaee N, Clark SW. Salbutamol aerosol delivery in man with the rondo spacer. Acta Therapeutica. 1991;17(1):49\u201358.","journal-title":"Acta Therapeutica"},{"issue":"2","key":"57_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/02770900701815727","volume":"45","author":"M Molimard","year":"2008","unstructured":"Molimard M, Le Gros V. Impact of patient-related factors on asthma control. J Asthma. 2008;45(2):109\u201313.","journal-title":"J Asthma"},{"issue":"2","key":"57_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1183\/09031936.02.00218402","volume":"19","author":"V Giraud","year":"2002","unstructured":"Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 2002;19(2):246\u201351.","journal-title":"Eur Respir J"},{"issue":"4","key":"57_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.rmed.2007.11.003","volume":"102","author":"F Lavorini","year":"2008","unstructured":"Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593\u2013604.","journal-title":"Respir Med"},{"issue":"1","key":"57_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1710-1492-9-8","volume":"9","author":"H Al-Jahdali","year":"2013","unstructured":"Al-Jahdali H, Ahmed A, Al-Harbi A, Khan M, Baharoon S, Bin Salih S, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy, Asthma Clin Immunol. 2013;9(1):8.","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"4","key":"57_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4104\/pcrj.2013.00084","volume":"22","author":"ML Levy","year":"2013","unstructured":"Levy ML, Hardwell A, McKnight E, Holmes J. Asthma patients\u2019 inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J. 2013;22(4):406\u201311.","journal-title":"Prim Care Respir J"},{"issue":"4","key":"57_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jaip.2017.01.004","volume":"5","author":"DB Price","year":"2017","unstructured":"Price DB, Rom\u00e1n-Rodr\u00edguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract. 2017;5(4):1071\u201381.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"57_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.1999.tb11656.x","volume":"53","author":"DB Price","year":"1999","unstructured":"Price DB, Pearce L, Powell SR, Shirley J, Sayers MK. Handling and acceptability of the Easi-breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract. 1999;53(1):31\u20136.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"57_CR20","first-page":"323","volume":"13","author":"V Giraud","year":"2009","unstructured":"Giraud V, Allaert FA. Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey. Eur Rev Med Pharmacol Sci. 2009;13(5):323\u201330.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"57_CR21","first-page":"7","volume":"5","author":"D Donnell","year":"2001","unstructured":"Donnell D. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device. Eur Rev Med Pharmacol Sci. 2001;5(1):7\u201316.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"57_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1586\/17476348.2014.854168","volume":"8","author":"S Salvi","year":"2014","unstructured":"Salvi S, Gogtay J, Aggarwal B. Use of breath-actuated inhalers in patients with asthma and COPD - an advance in inhalational therapy: a systematic review. Expert Rev Respir Med. 2014;8(1):89\u201399.","journal-title":"Expert Rev Respir Med"},{"issue":"12","key":"57_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/17425247.2019.1689957","volume":"16","author":"O Usmani","year":"2019","unstructured":"Usmani O, Roche N, Marshall J, Danagher H, Price D. An innovative corticosteroid\/long-acting \u03b22-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate\/formoterol fumarate for the treatment of asthma. Expert Opin Drug Deliv. 2019;16(12):1367\u201380.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"57_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3132\/pcrj.2007.00017","volume":"16","author":"M Sanders","year":"2007","unstructured":"Sanders M. Inhalation therapy: an historical review. Prim Care Respir J. 2007;16(2):71\u201381.","journal-title":"Prim Care Respir J"},{"issue":"9","key":"57_CR25","first-page":"1139","volume":"50","author":"PJ Anderson","year":"2005","unstructured":"Anderson PJ. History of aerosol therapy: liquid nebulization to MDIs to DPIs. Respir Care. 2005;50(9):1139\u201350.","journal-title":"Respir Care"},{"issue":"4","key":"57_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jamp.2015.1232","volume":"29","author":"N Roche","year":"2016","unstructured":"Roche N, Dekhuijzen PN. The evolution of pressurized metered-dose inhalers from early to modern devices. J Aerosol Med Pulm Drug Deliv. 2016;29(4):311\u201327.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"6","key":"57_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcrj.2006.09.002","volume":"15","author":"G Crompton","year":"2006","unstructured":"Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15(6):326\u201331.","journal-title":"Prim Care Respir J"},{"issue":"3","key":"57_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1183\/20734735.020318","volume":"14","author":"M Biddiscombe","year":"2018","unstructured":"Biddiscombe M, Usmani O. Is there a room for further innovation in inhaled therapy for airways disease? Breathe. 2018;14(3):217\u201324.","journal-title":"Breathe"},{"issue":"26","key":"57_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5260","volume":"5","author":"D Brocklebank","year":"2001","unstructured":"Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1\u2013149.","journal-title":"Health Technol Assess"},{"issue":"5","key":"57_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1053\/rmed.1999.0767","volume":"94","author":"J Lenney","year":"2000","unstructured":"Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med. 2000;94(5):496\u2013500.","journal-title":"EDICI Respir Med"},{"issue":"2","key":"57_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","volume":"150","author":"J Sanchis","year":"2016","unstructured":"Sanchis J, Gich I. Pedersen S; aerosol drug management improvement team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150(2):394\u2013406.","journal-title":"Chest"},{"issue":"1","key":"57_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12931-017-0710-y","volume":"19","author":"OS Usmani","year":"2018","unstructured":"Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19(1):10.","journal-title":"Respir Res"},{"issue":"3","key":"57_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/02770903.2015.1099160","volume":"53","author":"JA Westerik","year":"2016","unstructured":"Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma. 2016;53(3):321\u20139.","journal-title":"J Asthma"},{"issue":"12","key":"57_CR34","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.rmed.2011.07.004","volume":"105","author":"V Giraud","year":"2011","unstructured":"Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasibility and acceptability of training by pharmacists. Respir Med. 2011;105(12):1815\u201322.","journal-title":"Respir Med"},{"issue":"6","key":"57_CR35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2125.2005.02499.x","volume":"60","author":"HS Tomlinson","year":"2005","unstructured":"Tomlinson HS, Corlett SA, Allen MB, Chrystyn H. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge. Br J Clin Pharmacol. 2005;60(6):605\u201310.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"57_CR36","first-page":"563","volume":"15","author":"V Giraud","year":"2011","unstructured":"Giraud V, Allaert FA, Magnan A. A prospective observational study of patient training in use of the autohaler inhaler device: the sirocco study. Eur Rev Med Pharmacol Sci. 2011;15(5):563\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"57_CR37","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1378\/chest.104.5.1332","volume":"104","author":"KR Chapman","year":"1993","unstructured":"Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest. 1993;104(5):1332\u20137.","journal-title":"Chest"},{"issue":"10","key":"57_CR38","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1136\/thx.46.10.712","volume":"46","author":"SP Newman","year":"1991","unstructured":"Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46(10):712\u20136.","journal-title":"Thorax"},{"issue":"5","key":"57_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ageing\/20.5.379","volume":"20","author":"P Diggory","year":"1991","unstructured":"Diggory P, Bailey R, Vallon A. Effectiveness of inhaled bronchodilator delivery systems for elderly patients. Age Ageing. 1991;20(5):379\u201382.","journal-title":"Age Ageing"},{"issue":"2","key":"57_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2500\/aap.2018.39.4115","volume":"39","author":"NK Ostrom","year":"2018","unstructured":"Ostrom NK, Raphael G, Tillinghast J, Hickey L, Small CJ. Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma. Allergy Asthma Proc. 2018;39(2):117\u201326.","journal-title":"Allergy Asthma Proc"},{"key":"57_CR41","first-page":"37","volume":"4","author":"D Price","year":"2011","unstructured":"Price D, Haughney J, Sims E, Muzammil A, von Ziegenweidt J, Hillyer EV, et al. Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy. 2011;4:37\u201347.","journal-title":"J Asthma Allergy"},{"issue":"1","key":"57_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40413-015-0075-y","volume":"8","author":"D Price","year":"2015","unstructured":"Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8(1):26.","journal-title":"World Allergy Organ J"},{"key":"57_CR43","volume-title":"Flutiform k-haler combined summary of product characteristics and patient information leaflet","author":"Mundipharma International Ltd","year":"2017","unstructured":"Mundipharma International Ltd. Flutiform k-haler combined summary of product characteristics and patient information leaflet; 2017."},{"key":"57_CR44","doi-asserted-by":"publisher","first-page":"PA524","DOI":"10.1183\/1393003.congress-2017.PA524","volume":"50","author":"J Tuohy","year":"2017","unstructured":"Tuohy J, Marshall J, Danagher H. Plume spray force of three HFA-propelled ICS\/LABA combination inhalers. Eur Respir J. 2017;50:PA524. https:\/\/doi.org\/10.1183\/1393003.congress-2017.PA524.","journal-title":"Eur Respir J"},{"issue":"6","key":"57_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/jamp.2017.1385","volume":"30","author":"D Bell","year":"2017","unstructured":"Bell D, Mansfield L, Lomax M. A randomized, crossover trial evaluating patient handling, preference, and ease of use of the fluticasone propionate\/formoterol breath-triggered inhaler. J Aerosol Med Pulm Drug Deliv. 2017;30(6):425\u201334.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"57_CR46","doi-asserted-by":"publisher","first-page":"PA523","DOI":"10.1183\/1393003.congress-2017.PA523","volume":"50","author":"D Bell","year":"2017","unstructured":"Bell D, Mundin G, Lomax M, Woodward J, Dissanayake S, Overend T. Relative pulmonary bioavailability of fluticasone propionate\/formoterol via pressurised metered-dose inhaler and a novel breath-triggered inhaler [abstrac]. Eur Respir J. 2017;50:PA523. https:\/\/doi.org\/10.1183\/1393003.congress-2017.PA523.","journal-title":"Eur Respir J"},{"key":"57_CR47","doi-asserted-by":"publisher","first-page":"PA3950","DOI":"10.1183\/1393003.congress-2017.PA3950","volume":"50","author":"S Bell","year":"2017","unstructured":"Bell S, Mundin G, Lomax M, Woodward J, Dalvi P, Dissanayakeet S. Systemic bioavailability and pharmacodynamics of fluticasone propionate\/formoterol via pressurised metered-dose inhaler or a novel breath-triggered inhaler. Eur Respir J. 2017;50:PA3950. https:\/\/doi.org\/10.1183\/1393003.congress-2017.PA3950.","journal-title":"Eur Respir J"},{"key":"57_CR48","unstructured":"Holsbeke C, Marshall J, De Backer J, Vos W. In vitro lung deposition of fluticasone propionate\/formoterol (FP\/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles. Munich: European Respiratory Society Annual Congress; 2014:44;suppl 48, abstract."},{"issue":"8","key":"57_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/17476348.2016.1192464","volume":"10","author":"J De Backer","year":"2016","unstructured":"De Backer J, Holsbeke C, Vos W, Vinchurkar S, Dorinsky P, Rebello J, et al. Assessment of lung deposition and analysis of the effect of fluticasone\/salmeterol hydrofluoroalkane (HFA) pressurized metered dose inhaler (pMDI) in stable persistent asthma patients using functional respiratory imaging. Expert Rev Respir Med. 2016;10(8):927\u201333.","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"57_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/jamp.2013.1064","volume":"28","author":"J De Backer","year":"2015","unstructured":"De Backer J, Vos W, Vinchurkar S, Van Holsbeke C, Poli G, Claes R, et al. The effects of extrafine beclometasone\/formoterol on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. J Aerosol Med Pulm Drug Deliv. 2015;28(2):88\u201399.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"57_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.rmed.2018.03.029","volume":"138","author":"D Kappeler","year":"2018","unstructured":"Kappeler D, Sommerer K, Kietzig C, Huber B, Woodward J, Lomax M, et al. Pulmonary deposition of fluticasone propionate\/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler. Respir Med. 2018;138:107\u201314.","journal-title":"Respir Med"},{"key":"57_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","volume":"3","author":"C Nunes","year":"2017","unstructured":"Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1.","journal-title":"Asthma Res Pract"},{"issue":"6","key":"57_CR53","first-page":"323","volume":"23","author":"JP Barbosa","year":"2017","unstructured":"Barbosa JP, Ferreira-Magalh\u00e3es M, S\u00e1-Sousa A, Azevedo LA, Fonseca JA. Cost of asthma in Portuguese adults: a population-based, cost-of-illness study. Rev Port Pneumol (2006). 2017;23(6):323\u201330.","journal-title":"Rev Port Pneumol (2006)"},{"key":"57_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/COPD.S103335","volume":"11","author":"A Roggeri","year":"2016","unstructured":"Roggeri A, Micheletto C, Roggeri DP. Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues. Int J Chron Obstruct Pulmon Dis. 2016;11:597\u2013602.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"57_CR55","doi-asserted-by":"publisher","first-page":"A350","DOI":"10.1016\/j.jval.2015.09.638","volume":"18","author":"A Lewis","year":"2015","unstructured":"Lewis A, Blackney M, Garcia Bujalance L. S\u00e1nchez-de la Rosa R, Torvinen S, Plich a. the potential for improved inhalation technique with Duoresp\u00ae Spiromax\u00ae (budesonide + formoterol fumarate dihydrate) compared with commonly prescribed dry powder inhalers for the management of asthma and chronic obstructive pulmonary disease in Spain: estimated impact on number and cost of unscheduled healthcare events. Value Health. 2015;18(7):A350\u20131.","journal-title":"Value Health"},{"issue":"9","key":"57_CR56","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10198-018-0974-2","volume":"19","author":"R Forster","year":"2018","unstructured":"Forster R, Ratcliffe A, Lewis M, Crossley A, Bastida JL, Dunlop WCN. Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort. Eur J Health Econ. 2018;19(9):1303\u201318.","journal-title":"Eur J Health Econ"}],"container-title":["Asthma Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40733-020-00057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40733-020-00057-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40733-020-00057-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T02:01:33Z","timestamp":1722996093000},"score":1,"resource":{"primary":{"URL":"https:\/\/asthmarp.biomedcentral.com\/articles\/10.1186\/s40733-020-00057-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/s40733-020-00057-7","relation":{},"ISSN":["2054-7064"],"issn-type":[{"value":"2054-7064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"3 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that no experiments were performed on humans or animals for this review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that no patient data appears in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"An educational grant from Mundipharma Pharmaceuticals LTd\u2019s is acknowledged.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}